ASRT
Assertio Therapeutics Inc
Halal Rating :
Last Price
$0.83
Last updated:
Market Cap
-
7D Change
2.86%
1 Year Change
-4.83%
Company Overview
Industries
Exchange
Next Earnings Date
Assertio Therapeutics Inc is a specialty pharmaceutical company that focuses on developing and commercializing products for neurology, inflammation, and pain management. The company markets FDA-approved products and has a portfolio that includes medications for various conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $29.2m | $33.01m | - | $761000.0 | 0.00% | 2.31% |
| June 30, 2024 | $31.13m | $35.5m | - | $758000.0 | 0.00% | 2.14% |
| March 31, 2024 | $32.45m | $37.54m | - | $757000.0 | 0.00% | 2.02% |
Company Impact
Help us evaluate Assertio Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.